“We and many others around the world, have developed an enormous body of laboratory and pre-clinical data, and a burgeoning body of clinical evidence addressing the potential that sulforaphane has, not only in the prevention of environmental carcinogenesis, but in the prevention or amelioration of a very large, diverse, and seemingly unrelated series of conditions…[that] include autism spectrum disorder (ASD), schizophrenia, bacterial and viral infections, prostate, lung, breast, skin, and head and neck cancers, osteoarthritis, type 2 diabetes, sickle cell disease, fatty liver, and asthma.” Read more here…
Reference: Fahey Jed W., Kensler Thomas W. The Challenges of Designing and Implementing Clinical Trials With Broccoli Sprouts… and Turning Evidence Into Public Health Action. Frontiers in Nutrition, Vol 8 . Apr 29, 2021